Loading...
Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan
BACKGROUND: This study assessed the effectiveness and safety of bosentan when administered to thromboangiitis obliterans (Buerger's disease) patients. METHODS: A clinical pilot study was designed in which patients with ulcer and/or pain at rest were treated with bosentan p.o. at a dose of 62.5...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Artigo |
| Language: | Inglês |
| Published: |
BioMed Central
2012
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3306190/ https://ncbi.nlm.nih.gov/pubmed/22333218 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-12-5 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|